Patents by Inventor Kenneth Schenkman

Kenneth Schenkman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10463286
    Abstract: A system and method for noninvasively determining the oxygenation of a tissue, for example, a muscle, in vivo uses optical methods to optically interrogate the tissue in both a visible wavelength range and a near infrared (NIR) wavelength range. The illuminating light is sculpted in intensity to approximately match the absorbance spectrum, for example, with the visible light having an intensity an order of magnitude greater than the NIR light. Training data is obtained from healthy patients in both the visible and NIR ranges simultaneously and used to calculate muscle oxygenation.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: November 5, 2019
    Assignee: University of Washington
    Inventors: Kenneth Schenkman, Lorilee Arakaki, Wayne Ciesielski, Jeremy Shaver
  • Publication number: 20170150912
    Abstract: A system and method for noninvasively determining the oxygenation of a tissue, for example, a muscle, in vivo uses optical methods to optically interrogate the tissue in both a visible wavelength range and a near infrared (NIR) wavelength range. The illuminating light is sculpted in intensity to approximately match the absorbance spectrum, for example, with the visible light having an intensity an order of magnitude greater than the NIR light. Training data is obtained from healthy patients in both the visible and NIR ranges simultaneously and used to calculate muscle oxygenation.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicant: University of Washington through its Center for Commercialization
    Inventors: Kenneth Schenkman, Lorilee Arakaki, Wayne Ciesielski, Jeremy Shaver
  • Patent number: 9591999
    Abstract: A system and method for noninvasively determining the oxygenation of a tissue, for example, a muscle, in vivo uses optical methods to optically interrogate the tissue in both a visible wavelength range and a near infrared (NIR) wavelength range. The illuminating light is sculpted in intensity to approximately match the absorbance spectrum, for example, with the visible light having an intensity an order of magnitude greater than the NIR light. Training data is obtained from healthy patients in both the visible and NIR ranges simultaneously and used to calculate muscle oxygenation.
    Type: Grant
    Filed: November 3, 2011
    Date of Patent: March 14, 2017
    Assignee: University of Washington through its Center for Commercialization
    Inventors: Kenneth Schenkman, Lorilee Arakaki, Wayne Ciesielski, Jeremy Shaver
  • Publication number: 20130225955
    Abstract: A system and method for noninvasively determining the oxygenation of a tissue, for example, a muscle, in vivo uses optical methods to optically interrogate the tissue in both a visible wavelength range and a near infrared (NIR) wavelength range. The illuminating light is sculpted in intensity to approximately match the absorbance spectrum, for example, with the visible light having an intensity an order of magnitude greater than the light. Training data is obtained from healthy patients in both the visible and NIR ranges simultaneously and used to calculate muscle oxygenation.
    Type: Application
    Filed: November 3, 2011
    Publication date: August 29, 2013
    Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
    Inventors: Kenneth Schenkman, Lorilee Arakaki, Wayne Ciesielski, Jeremy Shaver
  • Patent number: 8126527
    Abstract: This document discusses, among other things, quantification of hemoglobin content, and therefore blood volume, of muscle. An analysis of the optical spectra can determine the ratio of hemoglobin (Hb) to myoglobin (Mb) content in intact muscle. The peak position of the in vivo optical spectra from intact tissue is used to determine the ratio of Hb to Mb contributing to the optical signal. The wavelength of the peak is a linear function of the percent contribution of Hb to the optical spectra. Such analysis in combination with known Mb concentrations yields a non-invasive measure of the Hb content for in vivo muscle.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: February 28, 2012
    Assignee: University of Washington through its Center for Commercialization
    Inventors: David J. Marcinek, Kevin Conley, Kenneth A. Schenkman
  • Publication number: 20080200780
    Abstract: This document discloses, among other things, systems and methods for measuring a level of myoglobin, hemoglobin, and cytochrome using an optical probe coupled to a spectrometer. Multivariate analysis of the spectral data yields quantifiable cellular and mitochondrial characteristics.
    Type: Application
    Filed: November 29, 2007
    Publication date: August 21, 2008
    Inventors: Kenneth A. Schenkman, Lorilee S.L. Arakaki, Wayne A. Ciesielski, Eric O. Feigl, David H. Burns
  • Publication number: 20080033263
    Abstract: This document discusses, among other things, quantification of hemoglobin content, and therefore blood volume, of muscle. An analysis of the optical spectra can determine the ratio of hemoglobin (Hb) to myoglobin (Mb) content in intact muscle. The peak position of the in vivo optical spectra from intact tissue is used to determine the ratio of Hb to Mb contributing to the optical signal. The wavelength of the peak is a linear function of the percent contribution of Hb to the optical spectra. Such analysis in combination with known Mb concentrations yields a non-invasive measure of the Hb content for in vivo muscle.
    Type: Application
    Filed: August 3, 2006
    Publication date: February 7, 2008
    Inventors: David J. Marcinek, Kevin Conley, Kenneth A. Schenkman
  • Publication number: 20070265513
    Abstract: This document describes, among other things, monitoring of intracellular oxygenation using an optical probe coupled to a multi-wavelength spectrometer. Multivariate analysis of the spectrum data yields quantifiable cellular characteristics.
    Type: Application
    Filed: May 11, 2006
    Publication date: November 15, 2007
    Inventors: Kenneth Schenkman, Lorilee Arakaki, Wayne Ciesielski